Perelman School of Medicine

Philadelphia, Pennsylvania 19104

3 studies enrolling now · 8 studies all time

What they study most

Aortic Stenosis, Asperger Syndrome, Autism, Autism Spectrum Disorder, Autistic Disorder, Cardiovascular Disease and Lipoprotein(a), Corticobasal Degeneration, Pervasive Developmental Disorder, Progressive Supranuclear Palsy, Schizophrenia / Schizoaffective Disorder, Sjogren's Syndrome, Sjögren Syndrome

Studies at this site

• An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis — Recruiting now
• Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome — Completed
• NST-SPARK Open-Label Phase 1 STTR (IGNITE) — Starting soon
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome — Completed
• Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders — Completed
• Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers — Completed